Growing community of inventors

Steinhausen, Switzerland

Titus Kretzschmar

Average Co-Inventor Count = 3.67

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Titus KretzschmarAbdijapar Shamshiev (9 patents)Titus KretzschmarSimone Schmitt (6 patents)Titus KretzschmarStefanie Grabulovski (6 patents)Titus KretzschmarThorsten Alexander Schafer (3 patents)Titus KretzschmarAnnemarie Honegger (2 patents)Titus KretzschmarDouglas Phillips (1 patent)Titus KretzschmarSimone Schmitt (1 patent)Titus KretzschmarThorsten Alexander Schäfer (1 patent)Titus KretzschmarMiriam Droste (1 patent)Titus KretzschmarTitus Kretzschmar (9 patents)Abdijapar ShamshievAbdijapar Shamshiev (9 patents)Simone SchmittSimone Schmitt (6 patents)Stefanie GrabulovskiStefanie Grabulovski (6 patents)Thorsten Alexander SchaferThorsten Alexander Schafer (3 patents)Annemarie HoneggerAnnemarie Honegger (7 patents)Douglas PhillipsDouglas Phillips (1 patent)Simone SchmittSimone Schmitt (1 patent)Thorsten Alexander SchäferThorsten Alexander Schäfer (1 patent)Miriam DrosteMiriam Droste (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cell Medica Limited (4 from 9 patents)

2. Cell Medica Switzerland Ag (4 from 5 patents)

3. Delenex Therapeutics Ag (1 from 5 patents)


9 patents:

1. 11434294 - Binding members to PD-L1

2. 11407824 - Nucleic acids encoding antibodies against IL-1 beta

3. 11267884 - Antibody to human IL-1 beta

4. 10995138 - Nucleic acids encoding binding members to TNF alpha

5. 10626171 - Nucleic acid encoding antibody to human IL-1 beta

6. 10233238 - TNF alpha antibody or fragment thereof and methods of use

7. 10077302 - Method of inhibiting human IL-1 beta by administering an antibody to human IL-1 beta

8. 9914772 - Antibodies against IL-1 beta

9. 9404930 - Antibody to human IL-1 beta

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…